Logo Medical Science Monitor

Call: +1.631.470.9640
Mon - Fri 10:00 am - 02:00 pm EST

Contact Us

Logo Medical Science Monitor Logo Medical Science Monitor Logo Medical Science Monitor

24 June 2022: Clinical Research

Medroxyprogesterone Acetate for Abnormal Uterine Bleeding Due to Ovulatory Dysfunction: The Effect of 2 Different-Duration Regimens

Rukiye Ada Bender 12ABCDEFG*

DOI: 10.12659/MSM.936727

Med Sci Monit 2022; 28:e936727

Table 2 The menstruation pattern, need for prolonged medical treatment or surgical intervention, and hemogram parameter results of the women after retrospective analysis.

MPA* administration daysGroup A (n=22)Group B (n=30)p-value
11th & 25thMin–Max16th & 25thMin–Max
 Regular11 (%50)25 (%83.3)
 Oligomenorrhea01 (%3.3)
 Abnormal uterine bleeding11 (%50)5 (%16.7)
6 (%27.2)0
0.39
 Hysteroscopy3 (%13.6)1 (%3.3)
 Hysterectomy5 (%22.7)4 (%13.3)
11.90±1.549.7–14.812.35±1.288.21–14.40.25
6.7±4.129.8–44.837.4±3.3926.4–43.70.55
* Medroxyprogesterone acetate.

Your Privacy

We use cookies to ensure the functionality of our website, to personalize content and advertising, to provide social media features, and to analyze our traffic. If you allow us to do so, we also inform our social media, advertising and analysis partners about your use of our website, You can decise for yourself which categories you you want to deny or allow. Please note that based on your settings not all functionalities of the site are available. View our privacy policy.

Medical Science Monitor eISSN: 1643-3750
Medical Science Monitor eISSN: 1643-3750